InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.16
(
0.47%
)
US TECH 100
18,020.80
(
0.55%
)
Dow Jones
39,497.54
(
0.13%
)
Brent Oil
79.49
(
0.95%
)
Bitcoin
60,644.07
(
-1.77%
)
Post# of 252817
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120250
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 251757

Thursday, 05/09/2024 10:06:55 AM

Thursday, May 09, 2024 10:06:55 AM

Post# of 252817
In Jan 2024, NVO restarted selling lower-dose strengths of Wegovy in the US, which had been curtailed in Jun 2023 due to supply constraints. The reintroduction of lower-dose strengths lowered the average selling price for Wegovy in 1Q24 relative to prior quarters.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up